My Queue

There are no Videos in your queue.

Click on the Add to next to any video to save to your queue.

There are no Articles in your queue.

Click on the Add to next to any article to save to your queue.

There are no Podcasts in your queue.

Click on the Add to next to any podcast episode to save to your queue.

You're not following any authors.

Click the Follow button on any author page to keep up with the latest content from your favorite authors.

Javier Hasse

Javier Hasse

VIP Contributor
cannabis, biotech and entrepreneurship reporter

About Javier Hasse

Javier Hasse is the author of Start Your Own Cannabis Business (Entrepreneur Press 2018) as well as a writer and reporter with a focus on the cannabis and small-cap biotech industries and an advocate of marijuana legalization. He has had more than 4,500 articles published on a variety of mass media outlets including Playboy, CNBC High Times, Leafly, Benzinga, The Wall Street Journal's MarketWatch, Yahoo! News, Yahoo! Finance, CNN Money, MSN Money, Nasdaq, Morningstar, Microsoft, FOX Business, Investing Channel and many others.

Books By Javier Hasse

Start Your Own Cannabis Business

More From Javier Hasse

cannabis industry

12 Essential Conferences for Meeting Everyone You Need to Know to Succeed in Cannabis

Mark your calendars. These are the top 12 canna is conferences to go to over the next year.
Medical Marijuana

Here's the Medical Cannabis Super Bowl Ad CBS Refused to Run

Both CBS and the NFL lag far behind the American public on the subject of medical marijuana.
CannaStars

System Of A Down's Shavo Odadjian Gets Into the Weed Business

The bassist's company, 22Red, introduces cannabis lifestyle brand.
Intellectual Property

Protecting Your IP Is (No Surprise) Even Harder in the Cannabis Business

Asking the federal government for a patent or trademark on anything cannabis related is harder than with ordinary IP.
News and Trends

The World Health Organization Won't Reschedule Cannabis. Should We Care?

In a surprising development, the U.N. comitee decided to punt on their decision to recommend or reschedule cannabis.
Legal Marijuana

AG Jeff Sessions Was (Basically) Fired: The Cannabis Industry Reacts

We tried but we couldn't find anybody unhappy about it.
News and Trends

Exclusive: New Report Estimates Over $1 Billion In Cannabis-Derived Taxes For Nevada

It won't happen until 2024, but it looks like Nevada has hit the jackpot.
Entrepreneurs

Rapper Chris Webby Explains How Cannabis Fits Into the Routine of a Successful Entrepreneur

There is no contradiction between enjoying marijuana and building a busy, successful career.
Demographics

'Microdosing Moms' and 'Divorced Dads' Emerge Among Cannabis Consumers

Thanks to legalization and the ability to consume discretely by vaping or snacking on edibles, ever more adults are using cannabis.
CBD

The DEA Actually Didn't Reschedule CBD: Industry Insiders Explain What Epidiolex's Reclassification Really Means

For decades the DEA has insisted nothing derived from cannabis has any legitimate use. Epidiolex is the first exemption that many believe will lead to a new rule.
Cannabis

Report: Sales of Cannabis Concentrates Expected to Triple to $8.5B by 2022

Concentrates, already nearly a $3B market, appeal to people who are curious about cannabis but would never dream of smoking.
Retail Businesses

Meet the Entrepreneur Selling Weed In Non-Cannabis Stores Across Europe

A regulatory quirk opened the door and, inevitably, an entrepreneur stepped in.
Medical Marijuana

This South Pacific Country Is Sponsoring Research Seeking a Cannabis Treatment for Diabetes

Vanuatu, suffering a diabetes rate far higher than the world average, is hopeful locally grown marijuana can help.
CBD

Report: CBD Market To Hit $22 Billion By 2022

Sales of the hemp-based compound will surpass those of legal cannabis.
C-Suite

Exclusive: Former MTV and Conde Nast Exec Takes Cannabis CEO Role

The influx of top business talent is perhaps the clearest sign that cannabis is growing into a major industry.